Frederic Ernst Email & Phone Number

With over two decades of life sciences experience, I have navigated a dynamic career trajectory, accumulating knowledge and expertise across the pharmaceutical value chain. My focus lies in early pipeline strategy and development, particularly in the realm of ophthalmology, med tech, vaccines, and medicines for rare diseases. As a seasoned executive leader, I excel in setting a clear vision and strategy for projects from candidate selection to Proof of Concept, facilitating effective transitions to access development.My proficiency extends to commercial strategy and evaluation, where I have led and collaborated with product and disease area teams to craft competitive and sustainable strategies for pipeline molecules. I bring analytical rigor and strategic insight to ensure robust programs that create enduring value for patients, payers and HCPs.Beyond my core expertise, I have expanded my influence into Communications and digital health application, especially the DiGA applications. As a catalyst for change and connection, I excel in bringing about organizational transformation and fostering engagement.In addition, my ESG leadership capabilities, acquired at Imperial College, shine when leading cross-functional teams to enhance the sustainability of the business. I possess the ability to distill scientific and technical complexities into a business case, navigating payer and Health Technology Assessment (HTA) negotiations with finesse. Since 2012, I have successfully submitted 225 HTA applications across various regions.My commitment to enabling better data-driven decisions, accelerating development, and improving patient outcomes remains steadfast.

Listed skills include Strategic Planning, Market Access, Negotiation, Customer Service, and 4 others.